_edited.png)
Trump’s Cannabis Policy Approval Drops Amid Rescheduling Delays
Fast Facts
Who / Where: President Donald Trump, U.S. Department of Justice, DEA, marijuana consumers (national, including DC/MD/VA)
What changed: Approval among marijuana consumers for Trump’s cannabis policies fell as federal marijuana rescheduling remains delayed by ongoing hearings and legal challenges
Effective / Key date: October 8-15, 2026 (poll dates)
Status: Rescheduling proceedings stayed; no full implementation yet; congressional action stalled
DMV impact: Delays in rescheduling could affect access, market rules, and policy clarity for DC, Maryland, and Virginia users and businesses
The bottom line: National polling in October 2026 shows Donald Trump’s approval among cannabis consumers has plummeted amid prolonged delays in federal marijuana rescheduling, underscoring the critical importance of clear, timely cannabis policy reform for DMV voters and businesses.
As of mid-October 2026, President Donald Trump is seeing diminishing support from marijuana consumers nationwide and within the DMV region, due to mounting frustration over stalled federal cannabis rescheduling and continuing political ambiguity. A new poll by NuggMD, published by Marijuana Moment, reports that only 29% of surveyed cannabis users now approve or strongly approve of the Trump administration’s progress on marijuana, a dramatic slide from prior highs.
Why Are Marijuana Consumers Losing Faith in Trump's Cannabis Policies?
Poll data reported by Marijuana Moment indicate that marijuana consumers’ approval of Trump’s actions on cannabis has dropped sharply as the federal rescheduling process experiences prolonged procedural delays, ongoing legal challenges, and a lack of clear communication with patients, providers, and businesses.
After an initial boom in approval—peaking as high as 73% among cannabis consumers earlier in Trump’s current term, following a move to reclassify state-licensed medical cannabis under the Controlled Substances Act—sentiment has waned. Now, 51% of respondents are neutral or hold no strong opinion, while 20% outright disapprove. Republicans are still more supportive (46%) than Democrats (18%), highlighting ongoing partisan polarization around marijuana reform.
What Are the Latest Poll Results on Trump's Marijuana Approval?
According to Marijuana Moment, the newest NuggMD/Marijuana Moment poll (conducted October 8-15, 2026, margin of error ±3.83%) found only 29% of legal-market cannabis users nationwide support the President’s recent cannabis actions, down from 48% last quarter and 73% earlier in 2026. These declining approval numbers come as rescheduling hearings remain in limbo due to procedural objections, lawsuits, and a recent Government Accountability Office (GAO) report highlighting gaps in drug scheduling processes.
How Did the Federal Rescheduling Process Stall?
Attorney General Todd Blanche reclassified state-regulated medical marijuana and FDA-approved cannabis products from Schedule I to Schedule III by executive order earlier in 2026. A separate ongoing rescheduling process—overseen by a DEA administrative judge—could shift all marijuana, including recreational products, to Schedule III. However, following the conclusion of hearing testimony in July, proceedings were put on hold as critics filed further legal motions and challenges, particularly after the GAO report flagged systemic problem areas in federal scheduling practices.
Date | Event | What it means |
|---|---|---|
Early 2026 | Trump admin issues order to reschedule medical cannabis | State-licensed medical marijuana moved to Schedule III |
July 2026 | DEA hearing on broader rescheduling ends | Testimony concludes; next steps unclear |
Post-July 2026 | Proceedings stayed by legal motions | Implementation of Schedule III for all cannabis delayed |
October 2026 | NuggMD/Marijuana Moment poll conducted | Consumer approval for Trump’s cannabis actions drops to 29% |
What This Means for DC, Maryland and Virginia Residents
For medical and recreational users in DC, Maryland, and Virginia, the delayed rescheduling has immediate implications. Maryland’s medical marijuana program and its evolving recreational laws are shaped by federal policy, and many dispensaries monitor these changes closely. Virginia, which has only recently decriminalized and is gradually structuring its cannabis regulations, has residents and entrepreneurs especially attentive to shifting national legal standards. In Washington, DC—where gifting and limited commercial activity fill gaps left by Congressional restrictions—federal guidance is vital for local clarity and business compliance.
Uncertainty on rescheduling makes it hard for DMV businesses to plan delivery operations, navigate courier licensing, and ensure weed delivery compliance—especially since state-level frameworks often refer to federal scheduling for transport, banking, and insurance practices.
How Does DMV Cannabis Policy Respond to Federal Delays?
While DC, Maryland, and Virginia have each moved to relax cannabis enforcement in recent years, community stakeholders and delivery providers are in limbo. For example, Maryland’s dispensaries must reconcile state rules with ambiguous federal law, complicating their licensing and compliance issues. Virginia’s gradual move toward legal recreational use is constrained by the lack of consistent federal guidance, and DC’s unique legal status continues to create ambiguity for both consumers and weed delivery businesses.
How This Compares to Other States
States with robust recreational frameworks like Colorado or California have largely forged ahead with their own cannabis courier licensing and transport regulations, less dependent on federal classification. Maryland and Virginia must instead balance emerging state laws with federal uncertainty, which particularly impacts smaller delivery startups and multi-state operators seeking compliance consistency. Unlike established legal markets, DMV residents face more complexity in accessing regulated marijuana delivery and trusting the legal status of their providers.
Timeline and Next Steps
The timeline for final resolution remains uncertain. The DEA’s administrative judge concluded testimony in July, and the process was stayed thereafter by legal motions and the fallout from the latest GAO findings on federal scheduling procedures. With lawsuits active and a key House committee voting to halt implementation of rescheduling in May, nationwide change appears unlikely before the year’s end. For DMV businesses and consumers, continuing to follow state requirements for marijuana delivery compliance and licensing is essential until clear federal action occurs.
Next Steps for DMV Residents and Businesses
Monitor updates from local agencies about marijuana delivery regulations and state licensing changes
Maryland dispensaries should ensure ongoing compliance with both state and federal guidance, especially for courier operations
Virginia entrepreneurs should watch for movement on recreational structuring and related delivery licensing
DC residents and businesses must continue to heed local interpretations of federal law, particularly regarding gifting, medical access, and legal delivery options
Bud Lords Take: What’s Really at Stake for DMV Cannabis?
As a deeply embedded voice in the DC cannabis community, we see this stalled rescheduling as more than political theater. The continued back-and-forth at the federal level leaves local patients, delivery operators, and small businesses without certainty. That impacts everyday decisions—from hiring and insurance for Maryland delivery companies, to consumer trust over labeling and product safety in DC gifting markets, to future planning for Virginia’s slow march toward regulated adult use.
Our advice: stay cautious on weed delivery business expansion and compliance in the DMV until clear federal rescheduling is finalized, but stay vocal. Consumer engagement—through polls, local organizing, and pressure on Congress—directly shapes the laws that will, eventually, bring clarity to our markets. Every voice in the DMV counts.
1. What does federal cannabis rescheduling mean for Maryland medical dispensaries?
Federal rescheduling would reduce legal and banking risks for Maryland dispensaries, especially for delivery operations, but full benefits won’t be realized until implementation is complete.
2. Is weed delivery legal in DC, Maryland, and Virginia?
Delivery legality varies: Maryland allows licensed medical delivery; DC operates under a unique gifting system with limited commercial delivery; Virginia is still developing adult-use delivery rules. Always check current state guidance.
3. How do rescheduling delays impact weed delivery compliance?
Delays mean businesses must comply with current state and federal rules, maintain robust record-keeping, and meticulously vet courier licensing to avoid penalties.
4. Has the approval rating of Trump among cannabis consumers affected local policy?
While the poll signals waning trust in federal leadership, actual policy shifts in the DMV are still driven by state law and local advocacy, but federal ambiguity adds confusion for delivery businesses and consumers.
5. What should DMV cannabis delivery businesses do now?
Remain vigilant about state law changes, keep compliance records up-to-date, educate staff and customers, and participate in advocacy for clear, federal reforms that support safe, legal delivery.
Expert and Industry Insights
Industry leaders highlight that “Consumers want cannabis to be accessible, accepted, and accurately labeled,” emphasizing that clear policies and consistent federal directives are essential to regaining trust among voters (Tyler Elson, NuggMD, via Marijuana Moment). Prolonged uncertainty makes compliance complex and potentially costly, particularly for smaller DMV operators and new entrants who must navigate changing regulations with limited resources.
Conclusion: DMV Cannabis at a Crossroads
Federal delays in rescheduling marijuana are having ripple effects on state compliance, consumer trust, and business planning across the DMV. Whether you’re a medical patient in Maryland, a delivery entrepreneur in DC, or navigating Virginia’s emerging laws, remaining engaged and informed will be crucial. With Congress yet to finalize rescheduling in 2026, DMV stakeholders must continue to rely on state frameworks, closely watch federal developments, and push for pragmatic reforms that reflect the region’s distinct needs and aspirations.
Have a cannabis story, local update, or strain you want our newsroom to cover? Request a story →
Written by Market Maven AI
Bud Lords AI Cannabis News Writer
Business and finance expert voice. Covers dispensary news, MSO developments, market trends, and financial analysis with industry insight.
Expertise: business · finance
This AI-assisted article was created using the named Bud Lords newsroom personality and reviewed under Bud Lords editorial standards.
Comments